SCHEMBL7400636

SCHEMBL7400636

O=C(O)c1ccc2c(c1)C(=O)N=CC2

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP2 O95551 2/20 0.50
ALDH1A1 P00352 3/20 0.43
SRD5A2 P31213 4/20 0.42
TTR P02766 2/20 0.42
PTPRC P08575 2/20 0.41
SRD5A1 P18405 3/20 0.39
POLB P06746 3/20 0.39
KMT2A Q03164 1/20 0.39
KDM4E B2RXH2 3/20 0.38
HPGD P15428 1/20 0.38
ENPP2 Q13822 1/20 0.38
HSD17B10 Q99714 1/20 0.38
MAPT P10636 2/20 0.37
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA4 P22748 1/20 0.37
CA9 Q16790 1/20 0.37
KDM6B O15054 1/20 0.37
TET3 O43151 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7001972 0.87 SRD5A2 (0.46) TDP2ALDH1A1SRD5A2TTRPTPRC
SCHEMBL5138970 0.77 ALDH1A1 (0.47) TDP2ALDH1A1SRD5A2SRD5A1POLB
SCHEMBL3199131 0.74 ALDH1A1 (0.47) ALDH1A1SRD5A2SRD5A1POLBKMT2A
SCHEMBL30740688 0.70 TDP2 (0.46) TDP2ALDH1A1SRD5A2TTRPTPRC
SCHEMBL17327530 0.69 TDP2 (0.62) TDP2ALDH1A1SRD5A2TTRPTPRC
SCHEMBL7050731 0.69 TTR (0.58) TDP2ALDH1A1SRD5A2TTRPTPRC
SCHEMBL15446326 0.69 ALDH1A1 (0.46) TDP2ALDH1A1SRD5A2TTRPTPRC
SCHEMBL5879567 0.69 TDP2 (0.61) TDP2ALDH1A1SRD5A2TTRPTPRC
SCHEMBL5067253 0.69 TDP2 (0.56) TDP2ALDH1A1SRD5A2TTRPTPRC
SCHEMBL17824647 0.69 CA1 (0.45) TDP2ALDH1A1POLBMAPTCA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242120-A2 COMBINATIONS OF GROWTH FACTORS AND I:UPA OR I:MMP FOR THE TREATMENT OF DAMAGED TISSUE Pfizer Limited (GB) 2002-09-25 EP disclosed
WO-2001049309-A2 COMBINATIONS OF GROWTH FACTORS AND I: UPA OR I: MMP FOR THE TREATMENT OF DAMAGED TISSUE PFIZER LIMITED (GB) 2001-07-12 WO disclosed